002932 Stock Overview
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥19.56 |
52 Week High | CN¥25.20 |
52 Week Low | CN¥14.81 |
Beta | 0.61 |
11 Month Change | 9.09% |
3 Month Change | 15.67% |
1 Year Change | -20.68% |
33 Year Change | -36.66% |
5 Year Change | 75.56% |
Change since IPO | 106.44% |
Recent News & Updates
Shareholder Returns
002932 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | -1.3% | -5.6% | -6.7% |
1Y | -20.7% | -10.2% | 1.9% |
Return vs Industry: 002932 underperformed the CN Medical Equipment industry which returned -10.2% over the past year.
Return vs Market: 002932 underperformed the CN Market which returned 1.9% over the past year.
Price Volatility
002932 volatility | |
---|---|
002932 Average Weekly Movement | 5.8% |
Medical Equipment Industry Average Movement | 8.6% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 12.5% |
10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 002932 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002932's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 1,547 | Chen Li Li | www.mdeasydiagnosis.com |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Fundamentals Summary
002932 fundamental statistics | |
---|---|
Market cap | CN¥4.36b |
Earnings (TTM) | CN¥10.56m |
Revenue (TTM) | CN¥349.23m |
412.8x
P/E Ratio12.5x
P/S RatioIs 002932 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002932 income statement (TTM) | |
---|---|
Revenue | CN¥349.23m |
Cost of Revenue | CN¥94.75m |
Gross Profit | CN¥254.47m |
Other Expenses | CN¥243.91m |
Earnings | CN¥10.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.047 |
Gross Margin | 72.87% |
Net Profit Margin | 3.03% |
Debt/Equity Ratio | 0.05% |
How did 002932 perform over the long term?
See historical performance and comparison